<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss">

<channel>
	<title>Yahoo! Canada Finance: Drug Manufacturers Industry News</title>
	<link>http://ca.news.finance.yahoo.com/industry/drugs</link>
	<description><![CDATA[The latest news on the Drug Manufacturers industry from Yahoo! Canada Finance]]></description>
	<language>en-us</language>
	<copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright>
	<lastBuildDate>Sat, 07 Nov 2009 02:00:49 GMT</lastBuildDate>
	<ttl>5</ttl>
	<image>
		<title>Yahoo! Canada Finance</title>
		<width>142</width>
		<height>18</height>
		<link>http://ca.finance.yahoo.com/</link>
		<url>http://l.yimg.com/a/i/ca/fi/ma_5.gif</url>
	</image>

	<item><title><![CDATA[Research and Markets: The 2010 Report on Anti-Obesity Drugs: World Market Segmentation by City]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-2010-report-anti-obesity-drugs-world.html</link><description><![CDATA[<p>Business Wire -       Research and Markets (http://www.researchandmarkets.com/resea
rch/c02179/the_2010_report_on) 
      has announced the addition of the "The 
      2010 Report on Anti-Obesity Drugs: World Market Segmentation by City" 
      report to their offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-2010-report-anti-obesity-drugs-world.html</guid><pubDate>Sat, 07 Nov 2009 02:00:49 GMT</pubDate></item><item><title><![CDATA[Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-halozyme-study-results-demonstrate-significantly-absorption-variability-insulin.html</link><description><![CDATA[<p>Business Wire -       Halozyme Therapeutics, Inc. (Nasdaq:HALO) today announced insulin 
      variability study results that demonstrated reduced intrasubject 
      absorption variability for the combination of lispro, a meal time analog 
      insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of 
      lispro alone.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-halozyme-study-results-demonstrate-significantly-absorption-variability-insulin.html</guid><pubDate>Sat, 07 Nov 2009 02:00:27 GMT</pubDate></item><item><title><![CDATA[GlaxoSmithKline and XenoPort Announce Extension of GSK1838262 (XP13512) FDA Review Date to February 9, 2010]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-glaxosmithkline-xenoport-announce-extension-gsk1838262-xp13512-fda-review.html</link><description><![CDATA[<p>Business Wire -       GlaxoSmithKline (NYSE: GSK) and XenoPort, Inc. (Nasdaq: XNPT) today 
      announced that the U.S.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-glaxosmithkline-xenoport-announce-extension-gsk1838262-xp13512-fda-review.html</guid><pubDate>Sat, 07 Nov 2009 01:15:22 GMT</pubDate></item><item><title><![CDATA[SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-scolr-pharma-inc-reports-third-quarter-2009-financial.html</link><description><![CDATA[<p>PRNewswire -  SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.  </p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-scolr-pharma-inc-reports-third-quarter-2009-financial.html</guid><pubDate>Sat, 07 Nov 2009 00:10:37 GMT</pubDate></item><item><title><![CDATA[Ergoresearch Announces the Resignation of Its Recently Appointed V-P Finance]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/28/link-f-ccnmatthews-ergoresearch-announces-resignation-its-recently-appointed-v-p.html</link><description><![CDATA[<p>Marketwire - Ergoresearch Ltd "Ergoresearch" (TSX VENTURE:ERG), announces the resignation of Mr. Michel Pare who had...</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/28/link-f-ccnmatthews-ergoresearch-announces-resignation-its-recently-appointed-v-p.html</guid><pubDate>Fri, 06 Nov 2009 23:38:25 GMT</pubDate></item><item><title><![CDATA[Authentidate Introduces New Interface for Inscrybe Healthcare with Definitive Homecare Solutions' CPR+

Inscrybe Healthcare included in CPR+ Integrate]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-authentidate-introduces-new-interface-inscrybe-healthcare-definitive-homecare.html</link><description><![CDATA[<p>PRNewswire -  Authentidate Holding Corp. (Nasdaq: ADAT), a worldwide provider of secure Health Information Exchange and workflow management services, has introduced an interface that allows InscrybeÂ® Healthcare to be easily integrated with one of the homecare industry's leading information systems, Definitive Homecare Solutions' CPR+(TM).</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-authentidate-introduces-new-interface-inscrybe-healthcare-definitive-homecare.html</guid><pubDate>Fri, 06 Nov 2009 23:08:07 GMT</pubDate></item><item><title><![CDATA[Cardiome to Release Third Quarter Results]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/30/link-f-cnw-cardiome-release-third-quarter-results.html</link><description><![CDATA[<p>CNW Group -  Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it will report financial results for the third quarter ended September 30, 2009 on the morning of Monday, November 9, 2009.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/30/link-f-cnw-cardiome-release-third-quarter-results.html</guid><pubDate>Fri, 06 Nov 2009 23:00:53 GMT</pubDate></item><item><title><![CDATA[Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-hospira-present-piper-jaffray-21st-annual-health-care.html</link><description><![CDATA[<p>PRNewswire -  Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Piper Jaffray 21st Annual Health Care Conference on Wednesday, Dec. 2, 2009 in New York City.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-hospira-present-piper-jaffray-21st-annual-health-care.html</guid><pubDate>Fri, 06 Nov 2009 22:36:52 GMT</pubDate></item><item><title><![CDATA[CardioNet, Inc. Reports Third Quarter 2009 Financial Results]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-cardionet-inc-reports-third-quarter-2009-financial-results.html</link><description><![CDATA[<p>Business Wire -       CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology 
      company with an initial focus on the diagnosis and monitoring of cardiac 
      arrhythmias, today reported results for the third quarter and nine 
      months ended September 30, 2009.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-cardionet-inc-reports-third-quarter-2009-financial-results.html</guid><pubDate>Fri, 06 Nov 2009 22:14:38 GMT</pubDate></item><item><title><![CDATA[Recession Continues to Depress Sales at Allied Healthcare Products]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-recession-continues-depress-sales-allied-healthcare-products.html</link><description><![CDATA[<p>PRNewswire -  Recession in domestic and international markets continued to depress sales for Allied Healthcare Products in the first quarter of fiscal year 2010 ending September 30, 2009.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-recession-continues-depress-sales-allied-healthcare-products.html</guid><pubDate>Fri, 06 Nov 2009 21:57:36 GMT</pubDate></item><item><title><![CDATA[Owens & Minor to Participate in Three Upcoming Investor Events]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-owens-minor-participate-three-upcoming-investor-events.html</link><description><![CDATA[<p>Business Wire -       Owens & Minor (NYSE: OMI) today updated its Investor Relations calendar 
      with three upcoming events.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-owens-minor-participate-three-upcoming-investor-events.html</guid><pubDate>Fri, 06 Nov 2009 21:30:51 GMT</pubDate></item><item><title><![CDATA[Floridas Agency for Health Care Administration Previews Online Personal Health Records for Medicaid Recipients]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-floridas-agency-health-care-administration-previews-online-personal.html</link><description><![CDATA[<p>Business Wire -       Florida&#x2019;s Agency for Health Care Administration (Agency) has previewed 
      the first phase of Florida&#x2019;s free, Internet-based personal health 
      record, My Florida Health eBook and My Florida eBaby Book.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-floridas-agency-health-care-administration-previews-online-personal.html</guid><pubDate>Fri, 06 Nov 2009 21:19:31 GMT</pubDate></item><item><title><![CDATA[Covidien Completes Acquisition of Aspect Medical Systems Inc.]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-covidien-completes-acquisition-aspect-medical-systems-inc.html</link><description><![CDATA[<p>Business Wire -       Covidien (NYSE: COV), a leading global provider of healthcare products, 
      today announced that it has completed the previously announced 
      acquisition of Aspect Medical Systems Inc. for an aggregate 
      consideration of approximately &#36;210 million, net of cash and short-term 
      investments acquired.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-covidien-completes-acquisition-aspect-medical-systems-inc.html</guid><pubDate>Fri, 06 Nov 2009 21:18:57 GMT</pubDate></item><item><title><![CDATA[Ferro Announces Closing of Common Stock Offering]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-ferro-announces-closing-common-stock-offering.html</link><description><![CDATA[<p>Business Wire -       Ferro Corporation (NYSE: FOE) announced today that it has closed on its 
      previously announced common stock offering.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-ferro-announces-closing-common-stock-offering.html</guid><pubDate>Fri, 06 Nov 2009 21:15:34 GMT</pubDate></item><item><title><![CDATA[Healthcare Trust of America, Inc. Executes Agreement to Acquire a 66,339 SF Medical Office Building Located in Englewood, Colorado]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-healthcare-trust-america-inc-executes-agreement-acquire-66.html</link><description><![CDATA[<p>PRNewswire -  Healthcare Trust of America, Inc. (the "REIT"), a self-managed, non-traded, real estate investment trust, announced the execution of a Purchase and Sale Agreement (the "Agreement") to acquire a medical office building located in Englewood, Colorado for approximately &#36;18,600,000. </p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-healthcare-trust-america-inc-executes-agreement-acquire-66.html</guid><pubDate>Fri, 06 Nov 2009 21:14:20 GMT</pubDate></item><item><title><![CDATA[Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-oxygen-biotherapeutics-inc-announces-1-15-reverse-stock.html</link><description><![CDATA[<p>PRNewswire -  Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that a previously approved reverse split of its common stock will take effect at the start of trading on Monday, Nov. 9, 2009 on a 1-for-15 split-adjusted basis.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-oxygen-biotherapeutics-inc-announces-1-15-reverse-stock.html</guid><pubDate>Fri, 06 Nov 2009 21:05:05 GMT</pubDate></item><item><title><![CDATA[Microbix Biosystems Re-files Annual Results With OSC]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/30/link-f-cnw-microbix-biosystems-re-files-annual-results-osc.html</link><description><![CDATA[<p>CNW Group -  Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended September 30, 2008.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/30/link-f-cnw-microbix-biosystems-re-files-annual-results-osc.html</guid><pubDate>Fri, 06 Nov 2009 21:00:25 GMT</pubDate></item><item><title><![CDATA[Centene Corporation to Present at Upcoming Healthcare Conferences]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-centene-corporation-present-upcoming-healthcare-conferences.html</link><description><![CDATA[<p>PRNewswire -  Centene Corporation (NYSE: CNC) today announced that it will present at two upcoming healthcare conferences over the next few weeks.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-centene-corporation-present-upcoming-healthcare-conferences.html</guid><pubDate>Fri, 06 Nov 2009 21:00:19 GMT</pubDate></item><item><title><![CDATA[Watson to Present at Credit Suisse Healthcare Conference]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-watson-present-credit-suisse-healthcare-conference.html</link><description><![CDATA[<p>PRNewswire -  Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson's president and chief executive officer, will provide an overview and update of the Company's business at the Credit Suisse 18th Annual Healthcare Conference on Wednesday, November 11, 2009 at 12:00 pm Eastern Standard Time.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-watson-present-credit-suisse-healthcare-conference.html</guid><pubDate>Fri, 06 Nov 2009 21:00:19 GMT</pubDate></item><item><title><![CDATA[PharMerica to Present at the Credit Suisse 18th Annual Healthcare Conference]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-pharmerica-present-credit-suisse-18th-annual-healthcare-conference.html</link><description><![CDATA[<p>Business Wire -       PharMerica Corporation (NYSE: PMC), a national provider of institutional 
      pharmacy and hospital pharmacy management services, today announced that 
      Gregory S.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-pharmerica-present-credit-suisse-18th-annual-healthcare-conference.html</guid><pubDate>Fri, 06 Nov 2009 20:39:25 GMT</pubDate></item><item><title><![CDATA[DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-dusa-pharmaceuticals-present-merriman-curhan-ford-investor-summit.html</link><description><![CDATA[<p>PRNewswire -  DUSA Pharmaceuticals, Inc.(Â®) (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan(Â®) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Merriman Curhan Ford Investor Summit 2009 on Tuesday, November 10, 2009 at 10:00 a.m. ET at the Hotel Sofitel in New York City.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-dusa-pharmaceuticals-present-merriman-curhan-ford-investor-summit.html</guid><pubDate>Fri, 06 Nov 2009 20:26:49 GMT</pubDate></item><item><title><![CDATA[Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/30/link-f-cnw-helix-biopharma-present-merriman-curhan-ford-s-investor.html</link><description><![CDATA[<p>CNW Group -  Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/30/link-f-cnw-helix-biopharma-present-merriman-curhan-ford-s-investor.html</guid><pubDate>Fri, 06 Nov 2009 20:10:21 GMT</pubDate></item><item><title><![CDATA[Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2010 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/29/link-f-prime-zone-transition-therapeutics-hold-conference-call-first-quarter-fiscal.html</link><description><![CDATA[<p>GlobeNewswire - Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Tuesday, November 10, 2009 at 4:30 P.M.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/29/link-f-prime-zone-transition-therapeutics-hold-conference-call-first-quarter-fiscal.html</guid><pubDate>Fri, 06 Nov 2009 20:06:16 GMT</pubDate></item><item><title><![CDATA[AIPL Announces Premier Opthalmic Pathology Consultation Group]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-aipl-announces-premier-opthalmic-pathology-consultation-group.html</link><description><![CDATA[<p>Business Wire -       American International Pathology Laboratories&#x2122; (AIPL&#x2122;) announces the 
      formation of the first ever multi-subspecialty group to diagnose 
      Opthalmic Pathology cases.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-aipl-announces-premier-opthalmic-pathology-consultation-group.html</guid><pubDate>Fri, 06 Nov 2009 20:04:28 GMT</pubDate></item><item><title><![CDATA[Celsion to Hold Third Quarter 2009 Financial Results Conference Call Tuesday, November 10, 2009]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-celsion-hold-third-quarter-2009-financial-results-conference.html</link><description><![CDATA[<p>Business Wire -       Celsion Corporation (NASDAQ:CLSN), a late stage clinical oncology 
      development company that is leveraging its heat activated liposomal 
      technology platform to encapsulate and deliver high concentrations of 
      proven chemotherapeutics, today announced that it will hold a conference 
      call to discuss third quarter 2009 results at 11:00 a.m.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-celsion-hold-third-quarter-2009-financial-results-conference.html</guid><pubDate>Fri, 06 Nov 2009 19:45:54 GMT</pubDate></item><item><title><![CDATA[Patterson Companies Second Quarter Conference Call Scheduled for November 19, 2009]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-patterson-companies-second-quarter-conference-call-scheduled-november.html</link><description><![CDATA[<p>Business Wire -       Patterson Companies (Nasdaq: PDCO) today announced that it will hold its 
      conference call to review operating results for the second quarter of 
      fiscal 2010 on Thursday, November 19 at 10:00 AM Eastern.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-patterson-companies-second-quarter-conference-call-scheduled-november.html</guid><pubDate>Fri, 06 Nov 2009 19:24:33 GMT</pubDate></item><item><title><![CDATA[Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-roper-industries-announces-acquisitions-enhance-growth-medical-toll.html</link><description><![CDATA[<p>PRNewswire -  <em>Roper Industries, Inc. </em>(NYSE: ROP)<em> </em>today announced that it has signed a definitive agreement to acquire Verathon, Inc., a leading provider of proprietary medical devices.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-roper-industries-announces-acquisitions-enhance-growth-medical-toll.html</guid><pubDate>Fri, 06 Nov 2009 19:00:31 GMT</pubDate></item><item><title><![CDATA[National Institutes of Health Secures Armory with Patent-Pending Technology]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-national-institutes-health-secures-armory-patent-pending-technology.html</link><description><![CDATA[<p>PRNewswire -  Auburn Hills, MI-based Law Enforcement Intelligent Devices, LLC (LEID) will be installing its locker system and patent-pending Biometric Access Control System(TM) (BACS) at the U.S. Department of Health and Human Services' National Institutes of Health (NIH) based in Bethesda, MD.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-national-institutes-health-secures-armory-patent-pending-technology.html</guid><pubDate>Fri, 06 Nov 2009 18:30:14 GMT</pubDate></item><item><title><![CDATA[The Lowe Law Firm Files Suit over Alleged Botox Overdose]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-lowe-law-firm-files-suit-alleged-botox-overdose.html</link><description><![CDATA[<p>Business Wire -       St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man 
      who experienced...</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-lowe-law-firm-files-suit-alleged-botox-overdose.html</guid><pubDate>Fri, 06 Nov 2009 18:27:23 GMT</pubDate></item><item><title><![CDATA[Research and Markets: Lebanon Pharmaceuticals and Healthcare Report Q4 2009]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-lebanon-pharmaceuticals-healthcare-report-q4-2009.html</link><description><![CDATA[<p>Business Wire -       Research and Markets (http://www.researchandmarkets.com/resea
rch/48b0c6/lebanon_pharmaceut) 
      has announced the addition of the "Lebanon 
      Pharmaceuticals and Healthcare Report Q4 2009" report to their 
      offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-lebanon-pharmaceuticals-healthcare-report-q4-2009.html</guid><pubDate>Fri, 06 Nov 2009 18:14:27 GMT</pubDate></item><item><title><![CDATA[Prestige Ameritech Reopening Former Kimberly-Clark Surgical Mask Factory to Fight H1N1, Create US Jobs]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-prestige-ameritech-reopening-former-kimberly-clark-surgical-mask.html</link><description><![CDATA[<p><a href="http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-prestige-ameritech-reopening-former-kimberly-clark-surgical-mask.html"><img src="http://d.yimg.com/bg/p/091106/business_wire/tc23042428.jpg" align="left" width="149" height="104"/></a>Business Wire -       Prestige 
      Ameritech is turning a vacant, former Kimberly-Clark surgical mask 
      factory into a Global Pandemic Preparedness and Response Center. 
      The 220,000 square foot facility, on 17 acres in North Richland Hills, 
      Texas, will open by January 31, 2010.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-prestige-ameritech-reopening-former-kimberly-clark-surgical-mask.html</guid><pubDate>Fri, 06 Nov 2009 18:02:27 GMT</pubDate></item><item><title><![CDATA[Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-phase-forward-named-private-sector-company-year-mass.html</link><description><![CDATA[<p>Business Wire -       Phase Forward (NASDAQ: PFWD), a leading provider of data management 
      solutions for clinical trials and drug safety, today announced the Mass 
      Technology Leadership Council, Inc. named Phase Forward Private Sector 
      Company of the Year at the 2009 Mass Technology Leadership Awards in 
      Boston last night.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-phase-forward-named-private-sector-company-year-mass.html</guid><pubDate>Fri, 06 Nov 2009 18:00:30 GMT</pubDate></item><item><title><![CDATA[Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-reissue-tables-biospecifics-technologies-corp-reports-third-quarter.html</link><description><![CDATA[<p>PRNewswire -  BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-reissue-tables-biospecifics-technologies-corp-reports-third-quarter.html</guid><pubDate>Fri, 06 Nov 2009 18:00:13 GMT</pubDate></item><item><title><![CDATA[Macomb County Announces Two Additional Communitywide H1N1 Flu Vaccine Clinics Saturday, Nov. 14 and 21; Clinic For Health Care Workers Only Set For No]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-macomb-county-announces-additional-communitywide-h1n1-flu-vaccine.html</link><description><![CDATA[<p>PRNewswire -  Two additional large community H1N1 influenza clinics have been scheduled by the Macomb County Health Department, the department announced today.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-macomb-county-announces-additional-communitywide-h1n1-flu-vaccine.html</guid><pubDate>Fri, 06 Nov 2009 17:56:28 GMT</pubDate></item><item><title><![CDATA[UHS Third Quarter 2009 Earnings Call]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-uhs-third-quarter-2009-earnings-call.html</link><description><![CDATA[<p>Business Wire -       Universal Hospital Services, Inc., a leading nationwide provider of 
      medical equipment outsourcing and lifecycle solutions, will hold its 
      quarterly conference call to discuss 2009 third quarter results on 
      Tuesday, November 10, 2009, at 10:00 a.m.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-uhs-third-quarter-2009-earnings-call.html</guid><pubDate>Fri, 06 Nov 2009 17:54:22 GMT</pubDate></item><item><title><![CDATA[CEL-SCI's L.E.A.P.S. H1N1 Flu Development Seen as Credibility Booster]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-cel-sci-s-l-e-p-s-h1n1.html</link><description><![CDATA[<p>Business Wire -       BioMedReports.com, the news portal which covers Wall Street's biomedical 
      sector and delivers financial and investment intelligence to a community 
      of highly informed investors, reports that one of several expected key 
      news developments has been announced by CEL-SCI Corporation (NYSE Amex: 
      CVM), today.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-cel-sci-s-l-e-p-s-h1n1.html</guid><pubDate>Fri, 06 Nov 2009 17:34:26 GMT</pubDate></item><item><title><![CDATA[Research and Markets: Latest Report for the United States Pharmaceuticals and Healthcare Industry as We Find out Healthcare Spending in 2008 Reached U]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-latest-report-united-states-pharmaceuticals-healthcare.html</link><description><![CDATA[<p>Business Wire -       Research and Markets (http://www.researchandmarkets.com/resea
rch/00af33/united_states_phar) 
      has announced the addition of the "United 
      States Pharmaceuticals and Healthcare Report Q4 2009" report to 
      their offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-latest-report-united-states-pharmaceuticals-healthcare.html</guid><pubDate>Fri, 06 Nov 2009 17:30:38 GMT</pubDate></item><item><title><![CDATA[FDA Lags on 510(k) Medical Device Approvals]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-fda-lags-510-k-medical-device-approvals.html</link><description><![CDATA[<p>Business Wire -       According to MassDevice.com, 
      the online business journal of the medical device industry, medical 
      device approval times under the Food & Drug Administration's 510(k) 
      clearance process jumped 30 percent between 2005 and 2008.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-fda-lags-510-k-medical-device-approvals.html</guid><pubDate>Fri, 06 Nov 2009 17:18:33 GMT</pubDate></item><item><title><![CDATA[Express Scripts to Present at Credit Suisse Healthcare Conference]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-express-scripts-present-credit-suisse-healthcare-conference.html</link><description><![CDATA[<p>PRNewswire -  Express Scripts, Inc. (Nasdaq: ESRX) announced that it will present at the Credit Suisse 18th Annual Healthcare Conference on November 12, 2009 at 7:30 a.m.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-express-scripts-present-credit-suisse-healthcare-conference.html</guid><pubDate>Fri, 06 Nov 2009 17:11:43 GMT</pubDate></item><item><title><![CDATA[Research and Markets: Brazil's Generic Medicines Continue to grow at a Higher Rate than Overall Pharmacy Sales, And Are Expected to Represent 20% Of t]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-brazil-s-generic-medicines-continue-grow.html</link><description><![CDATA[<p>Business Wire -       Research and Markets(http://www.researchandmarkets.co
m/research/b3f479/the_pharmaceutical) 
      has announced the addition of the "The 
      Pharmaceutical Market: Brazil" report to their offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-brazil-s-generic-medicines-continue-grow.html</guid><pubDate>Fri, 06 Nov 2009 17:00:18 GMT</pubDate></item><item><title><![CDATA["AIM"ING FOR BETTER ASTHMA CARE]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-aim-ing-better-asthma-care.html</link><description><![CDATA[<p>PRNewswire - </p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-aim-ing-better-asthma-care.html</guid><pubDate>Fri, 06 Nov 2009 16:59:25 GMT</pubDate></item><item><title><![CDATA[Research and Markets: In 2008, Argentina's Pharma Annual Sales Rose By 26.8% In Local Terms, Reaching 9.6 Billion Pesos (US$3.1 Billion)]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-2008-argentina-s-pharma-annual-sales.html</link><description><![CDATA[<p>Business Wire -       Research and Markets (http://www.researchandmarkets.com/resea
rch/a8887a/the_pharmaceutical) 
      has announced the addition of the "The 
      Pharmaceutical Market: Argentina" report to their offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-2008-argentina-s-pharma-annual-sales.html</guid><pubDate>Fri, 06 Nov 2009 16:25:23 GMT</pubDate></item><item><title><![CDATA[Washington Biotechnology & Biomedical Associations New Healthcare Economics in WA Breaking News is Powered by MedIntelliBase® Intelligence Services]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-washington-biotechnology-biomedical-associations-new-healthcare-economics-wa.html</link><description><![CDATA[<p>Business Wire -       Visitors to the newly branded and redesigned website of the Washington 
      Biotechnology & Biomedical Association (WBBA) to 
      be featured at the WBBA&#x2019;s Annual Meeting today will get free, timely, 
      Washington state-focused biotech and medtech news through its &#x201c;Economic 
      Issues in WA Healthcare&#x201d; Breaking News feature.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-washington-biotechnology-biomedical-associations-new-healthcare-economics-wa.html</guid><pubDate>Fri, 06 Nov 2009 16:10:24 GMT</pubDate></item><item><title><![CDATA[Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-caraco-pharmaceutical-laboratories-ltd-markets-generic-acular-r.html</link><description><![CDATA[<p>PRNewswire -  Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched ketorolac tromethamine ophthalmic solution, 0.5% following a final approval from the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA) for generic AcularÂ® ophthalmic solution on the first day following patent expiration.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-caraco-pharmaceutical-laboratories-ltd-markets-generic-acular-r.html</guid><pubDate>Fri, 06 Nov 2009 15:36:25 GMT</pubDate></item><item><title><![CDATA[Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-whole-foods-market-r-offers-natural-solutions-help.html</link><description><![CDATA[<p>PRNewswire -  Whole Foods Market (Nasdaq: WFMI), the leading natural and organic foods supermarket, offers seasonal wellness support and features a variety of products that naturally build the body's defenses and bolster the immune system.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-whole-foods-market-r-offers-natural-solutions-help.html</guid><pubDate>Fri, 06 Nov 2009 15:25:39 GMT</pubDate></item><item><title><![CDATA[Research and Markets: Consumption of Anxiolytics, Soporifics, Sedatives and Antidepressants in Portugal Increased By 32% between 2002 And 2008]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-consumption-anxiolytics-soporifics-sedatives-antidepressants.html</link><description><![CDATA[<p>Business Wire -       Research and Markets(http://www.researchandmarkets.co
m/research/5417ca/portugal_pharmaceu) 
      has announced the addition of the "Portugal 
      Pharmaceuticals and Healthcare Report Q4 2009" report to their 
      offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-consumption-anxiolytics-soporifics-sedatives-antidepressants.html</guid><pubDate>Fri, 06 Nov 2009 15:11:23 GMT</pubDate></item><item><title><![CDATA[Fresenius Medical Care North America Acquires Health IT Services Group, Acumen nEHR]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-fresenius-medical-care-north-america-acquires-health-services.html</link><description><![CDATA[<p>Business Wire -       Fresenius Medical Care North America, operator of the nation&#x2019;s leading 
      network of dialysis facilities, today announced it has purchased 
      Nashville-based Health IT Services Group (HITSG) and its portfolio of 
      products including Acumen nEHR, a nephrology-specific electronic health 
      record.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-fresenius-medical-care-north-america-acquires-health-services.html</guid><pubDate>Fri, 06 Nov 2009 15:09:36 GMT</pubDate></item><item><title><![CDATA[Locus Pharmaceuticals Announces Focus on Drug Discovery Collaboration Business, Branded as Ansaris]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-locus-pharmaceuticals-announces-focus-drug-discovery-collaboration-business.html</link><description><![CDATA[<p>Business Wire -       Locus Pharmaceuticals, a drug company that has developed its own 
      internal and partnered pipeline, focusing on oncology, immunology, and 
      inflammatory targets, today announced that in conjunction with a 
      transformation to a drug discovery collaboration business model, it has 
      created a new division, Ansaris, which will include most of its 
      operations and personnel.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-locus-pharmaceuticals-announces-focus-drug-discovery-collaboration-business.html</guid><pubDate>Fri, 06 Nov 2009 15:07:12 GMT</pubDate></item><item><title><![CDATA[HFMAs New PATIENT FRIENDLY BILLING® Report Offers Strategies for Achieving Revenue Cycle Excellence]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-hfmas-new-patient-friendly-billing-report-offers-strategies.html</link><description><![CDATA[<p>Business Wire -       Revenue cycle excellence can be achieved by all hospitals and health 
      systems, regardless of an organization&#x2019;s financial means or patient mix, 
      according to the Healthcare Financial Management Association&#x2019;s latest PATIENT 
      FRIENDLY BILLING&#x00ae; Project report, Strategies for a 
      High-Performance Revenue Cycle.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-hfmas-new-patient-friendly-billing-report-offers-strategies.html</guid><pubDate>Fri, 06 Nov 2009 15:04:54 GMT</pubDate></item><item><title><![CDATA[Research and Markets: Peru Pharmaceuticals and Healthcare Report Q4 2009 - Independent Forecasts and Competitive Intelligence on Peru's Pharmaceutical]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-research-markets-peru-pharmaceuticals-healthcare-report-q4-2009.html</link><description><![CDATA[<p>Business Wire -       Research and Markets (http://www.researchandmarkets.com/resea
rch/c80cfb/peru_pharmaceutica) 
      has announced the addition of the "Peru 
      Pharmaceuticals and Healthcare Report Q4 2009" report to their 
      offering.
</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-research-markets-peru-pharmaceuticals-healthcare-report-q4-2009.html</guid><pubDate>Fri, 06 Nov 2009 15:01:17 GMT</pubDate></item><item><title><![CDATA[Medtronic Receives Presidents E Award in Recognition of Its Support of U.S. Exports]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-medtronic-receives-presidents-e-award-recognition-its-support.html</link><description><![CDATA[<p>Business Wire -       Recognizing its significant contributions to increasing U.S. exports, 
      Medtronic, Inc., (NYSE: MDT) received President Barack Obama&#x2019;s &#x201c;E&#x201d; Award 
      on Thursday, Nov. 5.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-medtronic-receives-presidents-e-award-recognition-its-support.html</guid><pubDate>Fri, 06 Nov 2009 15:00:37 GMT</pubDate></item><item><title><![CDATA[CEL-SCI to Conduct First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University Sc]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/31/link-f-prnewswire-cel-sci-conduct-first-clinical-study-investigational-leaps.html</link><description><![CDATA[<p>PRNewswire -  CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that an Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for the Company's first clinical study to proceed.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/31/link-f-prnewswire-cel-sci-conduct-first-clinical-study-investigational-leaps.html</guid><pubDate>Fri, 06 Nov 2009 14:45:06 GMT</pubDate></item><item><title><![CDATA[PPD Completes Acquisition of Excel PharmaStudies]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/34/biz-f-business-wire-ppd-completes-acquisition-excel-pharmastudies.html</link><description><![CDATA[<p>Business Wire -       PPD, Inc. (Nasdaq: PPDI) today announced it has completed its 
      acquisition of Excel PharmaStudies, Inc., the market leader and one of 
      the largest contract research organizations in China.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/34/biz-f-business-wire-ppd-completes-acquisition-excel-pharmastudies.html</guid><pubDate>Fri, 06 Nov 2009 14:28:33 GMT</pubDate></item><item><title><![CDATA[Medicago announces $10,080,000 bought deal equity financing]]></title><link>http://ca.rd.yahoo.com/finance/news/rss/story/*http://ca.news.finance.yahoo.com/s/06112009/30/link-f-cnw-medicago-announces-10-080-000-bought-deal-equity.html</link><description><![CDATA[<p>CNW Group -  Medicago Inc. ("Medicago") (TSX-V: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into an agreement to sell, on a bought deal basis (the "Offering"), 14,000,000 subscription receipts (the "Subscription Receipts") at a price of C&#36;0.72 per Subscription Receipt to a syndicate of underwriters led by Paradigm Capital Inc., for gross proceeds to the Company of C&#36;10,080,000 million.</p><br clear=all> ]]></description><guid isPermaLink="false">/s/06112009/30/link-f-cnw-medicago-announces-10-080-000-bought-deal-equity.html</guid><pubDate>Fri, 06 Nov 2009 14:07:33 GMT</pubDate></item>	</channel>
</rss>
<!-- w4.americas.sp1.yahoo.com uncompressed/chunked Sat Nov  7 21:03:34 PST 2009 -->
